Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study on Everolimus and Drug Combination for Children with Relapsed or Refractory Pediatric Cancer

Recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
Study of SAR445877 and Cetuximab for Adults with Advanced Solid Tumors

Recruiting

2 1 1 1
Investigated Drugs:
Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

Recruiting

2 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
+5
Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
Study on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors

Recruiting

2 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- IPN01195
Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

Recruiting

1 1 1
Investigated Diseases:
- Haematological malignancy
- Neoplasm
Investigated Drugs:
- Zilovertamab Vedotin
+6
Safety and Tolerability of AZD4956 Alone or with Saruparib in Adults with Advanced Metastatic Solid Tumors (Phase I/IIa)

Not yet recruiting

2 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Saruparib
Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Fulvestrant
- Ly3484356
Study of BMS-986504 alone or in drug combination in adults with advanced or metastatic solid tumors with MTAP deletion

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
+1
Study of IDE849, IDE‑161 and durvalumab evaluating safety and efficacy in patients with DLL3‑positive tumors including small cell lung cancer

Not yet recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Durvalumab

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies